Inspire Medical Systems (INSP)

• Market cap: $4.31B
• 1 day: -3.67%
• 5 days: -4.35%
• 1 month: -12.26%
• 3 months: -21.82%
• 6 months: -28.88%
• Year to date: -23.52%
• 1 year: -35.75%
• 5 years: 107.66%
• 10 years: 479.26%
• Sector: Healthcare
• Industry: Medical Devices

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Employees: 1,246

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

39% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 44

33% more funds holding in top 10

Funds holding in top 10: 6 [Q3] → 8 (+2) [Q4]

4% more funds holding

Funds holding: 341 [Q3] → 353 (+12) [Q4]

0.64% more ownership

Funds ownership: 110.78% [Q3] → 111.43% (+0.64%) [Q4]

7% less repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 125

11% less capital invested

Capital invested by funds: $6.97B [Q3] → $6.2B (-$769M) [Q4]

26% less call options, than puts

Call options by funds: $54.8M | Put options by funds: $73.8M

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $175 21% upside
• Avg. target: $219 51% upside
• High target: $248 71% upside

9 analyst ratings

• positive: 7 78%
• neutral: 2 22%
• negative: 0 0%

Stifel Jonathan Block 0% 1-year accuracy 0 / 20 met price target	21% upside $175	Hold Maintained	21 Apr 2025
Keybanc Tim Rezvan 7% 1-year accuracy 3 / 46 met price target	49% upside $216	Overweight Maintained	21 Apr 2025
RBC Capital Shagun Singh 33% 1-year accuracy 22 / 66 met price target	49% upside $215	Outperform Maintained	15 Apr 2025
Truist Securities Richard Newitter 46% 1-year accuracy 22 / 48 met price target	62% upside $235	Buy Maintained	11 Feb 2025
Baird Mike Polark 50% 1-year accuracy 6 / 12 met price target	71% upside $248	Outperform Maintained	11 Feb 2025